medigraphic.com
Academia Mexicana de Neurología, A.C.

2011, Número 5

<< Anterior Siguiente >>

Rev Mex Neuroci 2011; 12 (5)


Síndrome de Kearns-Sayre: Reporte de caso y revisión de la literatura

Méndez-Herrera CR

Idioma: Español
Referencias bibliográficas: 23
Paginas: 262-265
Archivo PDF: 146.83 Kb.


RESUMEN

El síndrome de Kearns-Sayre es una enfermedad mitocondrial poco frecuente caracterizada por oftalmoplejía externa crónica progresiva y retinopatía pigmentaria de inicio antes de los 20 años de edad, que se asocia a un grupo heterogéneo de manifestaciones clínicas, entre las que se incluyen alteraciones de la conducción cardiaca, debilidad muscular, neuropatía periférica, diabetes mellitus, síndrome de baja talla y sordera neuro-sensorial.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bertini E, D’Amico A. Mitochondrial encephalomyopathies and related syndromes: brief review. Endocr Dev 2009; 14: 38-52.

  2. Di Mauro S. Mitochondrial myopathies. Curr Opin Rheumatol 2006; 18: 636-41.

  3. Kierdaszuk B, Jamrozik Z, Tonska K, Bartnik E, Kaliszewska M, Kaminska A, et al. Mitochondrial cytopathies: clinical, morphological and genetic characteristics. Neurol Neurochir Pol 2009; 43: 216-27.

  4. Falk MJ, Sondheimer N. Mitochondrial genetic diseases. Curr Opin Pediatr 2010; 22: 711-6.

  5. Angelini C, Bello L, Spinazzi M, Ferrati C. Mitochondrial disorders of the nuclear genome. Acta Myol 2009; 28: 16-23.

  6. Lamperti C, Zeviani M. Encephalomyopathies caused by abnormal nuclear- mitochondrial intergenomic cross-talk. Acta Myol 2009; 28: 2-11.

  7. Spinazzola A, Invernizzi F, Carrara F, Lamantea E, Donati A, Dirocco M, et al. Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis 2009; 32: 143-58.

  8. Maceluch JA, Niedziela M. The clinical diagnosis and molecular genetics of kearns-sayre syndrome: a complex mitochondrial encephalomyopathy. Pediatr Endocrinol Rev 2006; 4: 117-37.

  9. Carod-Artal FJ, Lopez GE, Solano A, Dahmani Y, Herrero MD, Montoya J. [Mitochondrial DNA deletions in Kearns-Sayre syndrome]. Neurologia 2006; 21: 357-64.

  10. Zago FLA, Shiokawa N. [Kearns-Sayre syndrome: two case reports]. Arq Bras Oftalmol 2009; 72: 95-8.

  11. Kearns TP, Sayre GP. Retinitis Pigmentosa, External Ophthalmoplegia, and Complete Heart Block: Unusual Syndrome with Histologic Study in One of Two Cases. AMA Arch Ophthalmol 1958; 60: 280-9.

  12. Rahman S, Hanna MG. Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases. J Neurol Neurosurg Psychiatry 2009; 80: 943-53.

  13. Thajeb P, Dai D, Chiang MF, Shyu WC. Genotype-phenotype correlation of maternally inherited disorders due to mutations in mitochondrial DNA. Taiwan J Obstet Gynecol 2006; 45: 201-7.

  14. Mkaouar-Rebai E, Chamkha I, Kammoun T, Chabchoub I, Aloulou H, Fendri N, et al. A case of Kearns-Sayre syndrome with two novel deletions (9.768 and 7.253 kb) of the mtDNA associated with the common deletion in blood leukocytes, buccal mucosa and hair follicles. Mitochondrion 2010; 10: 449-55.

  15. Yau EK, Chan KY, Au KM, Chow TC, Chan YW. A novel mitochondrial DNA deletion in a Chinese girl with Kearns-Sayre syndrome. Hong Kong Med J 2009; 15: 374-7.

  16. Wabbels B, Ali N, Kunz WS, Roggenkamper P, Kornblum C. [Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome: interdisciplinary diagnosis and therapy]. Ophthalmologe 2008; 105: 550-6.

  17. Laloi-Michelin M, Virally M, Jardel C, Meas T, Ingster-Moati I, Lombes A, et al. Kearns Sayre syndrome: an unusual form of mitochondrial diabetes. Diabetes Metab 2006; 32: 182-6.

  18. Berio A, Piazzi A. A case of Kearns-Sayre syndrome with autoimmune thyroiditis and complete atrio-ventricular block. Minerva Cardioangiol 2006; 54: 387-91.

  19. Berio A, Oliaro E, Piazzi A. Kearns-Sayre syndrome with corneal dystrophy, hypomagnesemia, GH deficiency, and reduced visual acuity. Panminerva Med 2008; 50: 83-4.

  20. Hernandez-Luis C, Garcia-Moran E, Rubio-Sanz J, Fernandez-Aviles F. [Kearns-Sayre syndrome: recurrent syncope and atrial flutter]. Rev Esp Cardiol 2007; 60: 89-90.

  21. Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, Elliott PM. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail 2010; 12: 114-21.

  22. Horvath R, Gorman G, Chinnery PF. How can we treat mitochondrial encephalomyopathies? Approaches to therapy. Neurotherapeutics 2008; 5: 558-68.

  23. Tarnopolsky MA, Raha S. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med Sci Sports Exerc 2005; 37: 2086-93.




2020     |     www.medigraphic.com